Peer-reviewed data shows remdesivir for COVID-19 improves time to recovery
Sunday, May 24, 2020 - 14:10
in Health & Medicine
The investigational antiviral remdesivir is superior to the standard of care for the treatment of COVID-19, according to a report published today in the New England Journal of Medicine. The preliminary analysis is based on data from the Adaptive COVID-19 Treatment Trial (ACTT), sponsored by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of […]